Table: Torii Pharmaceutical -2020 parent results
Feb 4 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 41.70 43.00 45.70
(-3.0 pct) (-31.3 pct) (+9.6 pct)
Operating 4.74 1.43 3.80
(+231.2 pct) (-71.1 pct) (-19.8 pct)
Recurring 4.97 1.69 4.10
(+193.8 pct) (-66.7 pct) (-17.5 pct)
Net 3.50 27.37 2.70
(-87.2 pct) (-22.8 pct)
EPS 124.47 yen 974.98 yen 96.14 yen
EPS Diluted 124.46 yen
Ann Div 48.00 yen 48.00 yen 48.00 yen
-Q2 Div 24.00 yen 24.00 yen 24.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)